Clinical Trial Update: Safety and Efficacy of UC-MSC in Patients With Acute Severe Graft-versus-host Disease [Phase 1, Phase 2]

View source ↗

Summary

This Phase 1/2 clinical trial evaluates the safety and efficacy of UC-MSC therapy for acute graft-versus-host disease. It is sponsored by the Affiliated Hospita…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• UC-MSC (umbilical cord-derived mesenchymal stem cells)

Snippet

Sponsor: Affiliated Hospital to Academy of Military Medical Sciences | Conditions: Acute GVH Disease | Phase 1, Phase 2 | Status: UNKNOWN